Blog

Flu Vaccine in Lung Cancer Patients Could Increase Immunotherapy Toxicities – Cancer Network


Cancer Network

Flu Vaccine in Lung Cancer Patients Could Increase Immunotherapy Toxicities
Cancer Network
Seasonal influenza vaccination resulted in increased risk of immune-related adverse events (AEs) in lung cancer patients treated with PD-1/PD-L1 checkpoint inhibitors in a small study. However, the risks of the flu itself may still outweigh the risks

2017-05-11 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.